HTA58 Cost-Utility Analysis of Palivizumab to Prevent Respiratory Syncytial Virus Infections in the Dominican Republic
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1487
https://www.valueinhealthjournal.com/article/S1098-3015(23)01587-5/fulltext
Title :
HTA58 Cost-Utility Analysis of Palivizumab to Prevent Respiratory Syncytial Virus Infections in the Dominican Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01587-5&doi=10.1016/j.jval.2023.03.1487
First page :
Section Title :
Open access? :
No
Section Order :
10887